Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S, Portacci A, Campisi R, Buonamico E, Pelaia C, Benfante A, Triggiani M, Spadaro G, Caiaffa MF, Scioscia G, Detoraki A, Valenti G, Papia F, Tomasello A, Crimi N, Scichilone N, Pelaia G, Carpagnano GE, Crimi C. Nolasco S, et al. Among authors: carpagnano ge. Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023. Front Immunol. 2023. PMID: 37457743 Free PMC article.
Severe asthma and long-term Benralizumab effectiveness in real-life.
Sposato B, Scalese M, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Pelaia G, Palmiero G, Di Tomassi M, Ronchi MC, Cameli P, Bargagli E, Ciambellotti L, Rizzello S, Sglavo R, Coppola A, Lacerenza LG, Gabriele M, Radovanovic D, Perrella A, Ricci A, Rogliani P. Sposato B, et al. Among authors: carpagnano ge. Eur Rev Med Pharmacol Sci. 2022 Oct;26(20):7461-7473. doi: 10.26355/eurrev_202210_30016. Eur Rev Med Pharmacol Sci. 2022. PMID: 36314316 Free article.
Influence of allergic status and nasal polyposis on long-term Benralizumab response in eosinophilic severe asthma.
Sposato B, Ricci A, Camiciottoli G, Carpagnano GE, Pelaia C, Santus P, Pelaia G, Palmiero G, Di Tomassi M, Ronchi MC, Cameli P, Bargagli E, Ciambellotti L, Rizzello S, Sglavo R, Coppola A, Lacerenza LG, Gabriele M, Radovanovic D, Perrella A, Rogliani P, Scalese M. Sposato B, et al. Among authors: carpagnano ge. Clin Ter. 2023 Jan-Feb;174(1):67-74. doi: 10.7417/CT.2023.2499. Clin Ter. 2023. PMID: 36655647 Free article.
Symptom versus exacerbation control: an evolution in GINA guidelines?
Latorre M, Pistelli R, Carpagnano GE, Celi A, Puxeddu I, Scichilone N, Spanevello A, Canonica GW, Paggiaro P. Latorre M, et al. Among authors: carpagnano ge. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231159261. doi: 10.1177/17534666231159261. Ther Adv Respir Dis. 2023. PMID: 37646243 Free PMC article. Review.
215 results